CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) (“Infinity” or the “Company”), a clinical-stage biotechnology company ...
If you’ve been around the whiskey world for a few years, you’ve probably been pitched on the concept of an infinity bottle at some point. This is a basic, long-term project that a whiskey fan can ...
– Infinity Previously Announced Definitive Merger Agreement with MEI Pharma to Advance Three Promising Clinical Oncology Candidates – Research and development expenses for 2022 were $32.4 million, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback